الفهرس | Only 14 pages are availabe for public view |
Abstract With advances in imaging and surgical techniques, the number of patients undergoing hepatic resection for liver tumors has significantly increased during the past two decades. Patients with primary hepatocellular carcinoma are often poor surgical candidates because of lack of hepatic reserve from coexisting liver or the presence of multiple lesions at the time of diagnosis. Additionally, because of underlying cirrhosis, patients are at high risk for the development of new tumor nodules. So alternative methods of the treatment that results in minimal damage to uninvolved hepatic parenchyma are necessary for most patients. Among these procedures are percutaneous ethanol ablation radiofrequency, Chemotherapy , and transcatheter arterial chemoembolization, which show disappointment as, regards the results and side effects. In the present study we demonstrate the therapeutic efficacy of combined transcatheter arterial chemoembolization and percutaneous ethanol injection therapy in the management of large hepatocellular carcinoma. |